Alaunos Therapeutics (TCRT) Current Leases (2019 - 2023)
Alaunos Therapeutics (TCRT) reported Current Leases of $307000.0 for Q3 2023, down 43.36% on a YoY basis from $542000.0 in Q3 2022, and down 9.44% quarter-over-quarter from $339000.0 in Q2 2023.
Alaunos Therapeutics (TCRT) Current Leases (2019 - 2023) Analysis & Trends
Alaunos Therapeutics has reported Current Leases for 5 years, with the latest figure at $307000.0 in Q3 2023.
- For the quarter ending Q3 2023, Current Leases fell 43.36% year-over-year to $307000.0; the trailing twelve-month figure through Sep 2023 stood at $307000.0 (down 43.36% YoY), and the FY2022 full-year result was $558000.0, down 23.46% from the prior year.
- Current Leases for Q3 2023 stood at $307000.0, down from $339000.0 in the prior quarter.
- The five-year high for Current Leases was $866000.0 in Q3 2020, with the low at $307000.0 in Q3 2023.
- Historically, Current Leases has averaged $666315.8 across 5 years, with a median of $710000.0 in 2021.
- Annual changes were most pronounced in 2020 — Current Leases grew 28.57% — and 2023, when it tumbled 43.36%.
- Alaunos Therapeutics' Current Leases stood at $774000.0 in 2019, then grew by 5.81% to $819000.0 in 2020, then retreated by 10.99% to $729000.0 in 2021, then slipped by 23.46% to $558000.0 in 2022, then plunged by 44.98% to $307000.0 in 2023.
- The last three Current Leases figures came in at $307000.0 (Q3 2023), $339000.0 (Q2 2023), and $575000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 575,000.00 |
| Dec 31, 2022 | 558,000.00 |
| Sep 30, 2022 | 542,000.00 |
| Jun 30, 2022 | 525,000.00 |
| Mar 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 729,000.00 |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | 765,000.00 |
| Mar 31, 2021 | 759,000.00 |
| Dec 31, 2020 | 819,000.00 |
| Sep 30, 2020 | 866,000.00 |
| Jun 30, 2020 | 838,000.00 |
| Mar 31, 2020 | 828,000.00 |
| Dec 31, 2019 | 774,000.00 |
| Sep 30, 2019 | 677,000.00 |
| Jun 30, 2019 | 660,000.00 |
| Mar 31, 2019 | 644,000.00 |